Traws Pharma (TRAW) Asset Utilization Ratio (2013 - 2025)
Traws Pharma (TRAW) posted quarterly Asset Utilization Ratio of 0.24 for Q4 2025, up 1714.72% year-over-year from 0.01 in Q4 2024, and up 19.31% quarter-over-quarter from 0.2 in Q3 2025.
Traws Pharma (TRAW) Asset Utilization Ratio (2013 - 2025) Analysis & Trends
Traws Pharma (TRAW) has reported Asset Utilization Ratio for 13 consecutive years, with 0.24 the latest figure, recorded in Q4 2025.
- In Q4 2025, Asset Utilization Ratio rose 1714.72% year-over-year to 0.24; the TTM figure through Dec 2025 stood at 0.24 (up 1714.72% YoY), while the FY2025 annual figure was 0.16, up 1553.18% from the prior year.
- Asset Utilization Ratio improved to 0.24 in Q4 2025 per TRAW's latest filing, from 0.2 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.24 in Q4 2025 and bottomed at 0.0 in Q4 2021.
- Historically, Asset Utilization Ratio has averaged 0.04 across 5 years, with a median of 0.01 in 2023.
- Annual changes were most pronounced in 2021 — Asset Utilization Ratio plunged 91.22% — and 2025, when it surged 1714.72%.
- Traws Pharma's Asset Utilization Ratio stood at 0.0 in 2021, then jumped by 38.86% to 0.01 in 2022, then soared by 67.24% to 0.01 in 2023, then soared by 46.68% to 0.01 in 2024, then soared by 1714.72% to 0.24 in 2025.
- Business Quant data shows TRAW's Asset Utilization Ratio at 0.24 in Q4 2025, 0.2 in Q3 2025, and 0.17 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.81 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.52 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.30 Bn | 60.11 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.77 Bn | 28.46 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | 0.13 |
| 10 | Traws Pharma | 5.54 Mn | 519,253.28 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.24 |
| Sep 30, 2025 | 0.20 |
| Jun 30, 2025 | 0.17 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.01 |